Back to search

Article

A prognostic signature based on ectopic reactivation of eight tissue-specific genes in Diffuse Large B Cell Lymphoma.

2026-04-27

Abstract excerpt

Diffuse Large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma in the Western world. First-line immunochemotherapy fails in approximately 30-40% of patients, with refractory and relapse patients presenting a dismal prognosis. Currently, these high-risk patients cannot be accurately identified at diagnosis. Using statistical modeling and machine learning approaches applied to large public DLBCL datase...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1ff6466d-0f54-5068-84c1-e5438a2dd057
DOI
10.64898/2026.04.23.26351580
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A prognostic signature based on ectopic reactivation of eight tissue-specific genes in Diffuse Large B Cell Lymphoma.DOI 10.64898/2026.04.23.26351580
Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosisSemantic proximity
Molecular classification and therapeutics in diffuse large B-cell lymphomaSemantic proximity
Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma.Semantic proximity
Prediction of Overall Survival Status of Diffuse Large B-Cell Lymphoma Using a Prognostic Classification ModelSemantic proximity
Cell-of-Origin in Diffuse Large B-Cell Lymphoma: Are the Assays Ready for the Clinic?Semantic proximity
Next-generation prognostic assessment for diffuse large B-cell lymphoma.Semantic proximity
Novel therapeutic targets in diffuse large B-cell lymphomaSemantic proximity
Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy ResistanceSemantic proximity
Promising personalized therapeutic options for diffuse large B-cell Lymphoma Subtypes with oncogene addictions.Semantic proximity
Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier: A CALYM Study.Semantic proximity
Dissecting diffuse large B-cell lymphoma heterogeneity: New insights from a state-specific molecular characterisation.Semantic proximity
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulationSemantic proximity
Select a neighboring publication to make it the new centre.